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Abstract
Alpha-synuclein (aSyn) is the main component of proteinaceous inclusions known as Lewy bodies (LBs), the typical
pathological hallmark of Parkinson’s disease (PD) and other synucleinopathies. Although aSyn is phosphorylated at low
levels under physiological conditions, it is estimated that ,90% of aSyn in LBs is phosphorylated at S129 (pS129).
Nevertheless, the significance of pS129 in the biology of aSyn and in PD pathogenesis is still controversial. Here, we
harnessed the power of budding yeast in order to assess the implications of phosphorylation on aSyn cytotoxicity,
aggregation and sub-cellular distribution. We found that aSyn is phosphorylated on S129 by endogenous kinases.
Interestingly, phosphorylation reduced aSyn toxicity and the percentage of cells with cytosolic inclusions, in comparison to
cells expressing mutant forms of aSyn (S129A or S129G) that mimic the unphosphorylated form of aSyn. Using high-
resolution 4D imaging and fluorescence recovery after photobleaching (FRAP) in live cells, we compared the dynamics of
WT and S129A mutant aSyn. While WT aSyn inclusions were very homogeneous, inclusions formed by S129A aSyn were
larger and showed FRAP heterogeneity. Upon blockade of aSyn expression, cells were able to clear the inclusions formed by
WT aSyn. However, this process was much slower for the inclusions formed by S129A aSyn. Interestingly, whereas the
accumulation of WT aSyn led to a marked induction of autophagy, cells expressing the S129A mutant failed to activate this
protein quality control pathway. The finding that the phosphorylation state of aSyn on S129 can alter the ability of cells to
clear aSyn inclusions provides important insight into the role that this posttranslational modification may have in the
pathogenesis of PD and other synucleinopathies, opening novel avenues for investigating the molecular basis of these
disorders and for the development of therapeutic strategies.
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Introduction
Protein misfolding and aggregation is an unavoidable and
widespread problem in biology. Cells evolved a series of quality
control mechanisms to ensure overall proteostasis and, in some
cases, to exploit the plasticity of diverse conformational states,
including those concealed in protein aggregates, as in the case of
certain types of prions. In other instances, protein aggregates can
be detrimental [1,2]. Protein inclusions made of alpha-Synuclein
(aSyn), known as Lewy bodies (LBs) are the pathological hallmark
of Parkinson’s disease (PD) and other disorders known as
synucleinopathies [3,4]. The normal function of aSyn is still
unclear, but it is thought to be involved in the regulation of
dopamine neurotransmission, vesicular trafficking and in synaptic
function and plasticity [5]. Although aSyn is phosphorylated at low
levels under physiological conditions, a striking 90% of aSyn is
phosphorylated at S129 (pS129) in LBs [6]. However, the
significance of pS129 in the pathogenesis of synucleinopathies is
unresolved. While studies in Drosophila melanogaster [7] and
transgenic mouse models of PD [8] showed that pS129 aSyn
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was pathogenic, studies in rats and in Caenorhabditis elegans failed to
associate toxicity with phosphorylation and suggested a role of
pS129 in the attenuation of aSyn induced neuronal dysfunction
[9,10]. However, no differences in toxicity or aggregate formation
were seen in a rat model [11]. Whether pS129 promotes or
prevents aggregation remains largely controversial [12–14].
The yeast Saccharomyces cerevisiae is a powerful model for the
study of protein misfolding due to the high conservation of the
quality control systems with all other eukaryotes, including
humans [15]. Although S. cerevisiae lacks an aSyn ortholog,
heterologous expression of the protein induces toxicity in a
concentration dependent manner and is associated with the
formation of cytoplasmic protein inclusions [16]. Moreover, a
network of highly conserved aSyn interactors was identified,
suggesting the protein can be studied using simple models such as
yeast, worms, or flies, in addition to mammalian models [17,18].
Several pathways involved in aSyn-associated toxicity in yeast are
conserved in other eukaryotic models of PD. This is the case of
apoptosis [16], lipid droplet accumulation [16], mitochondrial
dysfunction [19,20], proteasome impairment [16,21,22], oxidative
stress [21,23], autophagy and mitophagy dysfunction [24,25],
vesicle trafficking defects [16,26], and ER-to-Golgi trafficking
impairment [20,27,28].
PD pathogenesis is thought to be exacerbated from inefficient
protein clearance as consequence of dysfunction in protein
degradation [29,30]. Clearance of aSyn can occur through direct
proteolysis [31], the ubiquitin-proteasome system (UPS) [32] and/
or chaperone-mediated autophagy (CMA) [33]. However, under
pathological conditions, aSyn inhibits the proteasome [22,34] and
impairs chaperone-mediated autophagy, leading to the upregula-
tion of macroautophagy (hereafter referred as autophagy) [35,36].
Autophagy dysfunction plays a central role in PD [24,35,37] and
was shown to be required for aSyn degradation under pathological
conditions [38]. Accordingly, increasing evidence suggests the
existence of a complex cross-talk between different forms of
autophagy and also between autophagy and the proteasomal
degradation pathway, processes known to play distinct roles in the
clearance of specific species of aggregated aSyn [22,34,35,39,40].
In yeast, the clearance of aSyn inclusions has been associated
with both UPS and autophagocytic degradation pathways [41].
However, recent observations suggest the UPS may be less
relevant in mediating aSyn clearance [25].
Here, we explored the power of yeast genetics in order to gain
mechanistic insights into the role of S129 phosphorylation on aSyn
biology. Using mutants of aSyn that attempt to mimic either
phosphorylated (S129E) or unphosphorylated (S129A or S129G)
states aSyn, we found that blocking phosphorylation increases
aSyn toxicity and promotes the formation of cytosolic inclusions.
Our data are consistent with the involvement of phosphorylation
in the clearance of aSyn via autophagy.
Altogether, our study provides insight into the role of S129 aSyn
phosphorylation and opens novel avenues for additional studies in
higher model systems.
Results
Blockade of aSyn S129 phosphorylation promotes
toxicity and inclusion formation
To investigate the effect of aSyn phosphorylation in yeast, we
used strains carrying two copies of human SNCA cDNA integrated
in the genome, encoding either wild-type (WT), S129A, S129G, or
S129E mutant aSyn fused to GFP (aSyn-GFP), in order to block
(S129A or S129G) or mimic (S129E) phosphorylation, under the
regulation of a galactose inducible promoter (GAL1) (Table 1).
These strains were previously described and characterized [42]
and display a moderate level of aSyn toxicity compared to strains
described in other studies [16,27,28]. Growth and viability
(colony-forming units, CFUs) of the different strains were assessed
upon induction of aSyn expression (Figure 1A and S1A). We
observed an initial lag phase of ,2 hours in cells expressing either
WT or S129E aSyn-GFP, compatible with the carbon source
switch (Figure S1A). Subsequently, these strains resumed growth
and behaved similarly, growing slightly slower that the control cells
(Figure 1A).
In contrast, cells expressing the S129A mutant exhibited a
longer lag phase of ,6 hours (Figure S1A). During this period,
cells expressing S129A aSyn-GFP lost viability, as indicated by
propidium iodide (PI) staining of cells where membrane integrity
was compromised (Figure 1B). This was confirmed by spotting
assays (Figure S1B). In fact, 6 hours after induction of aSyn
expression, 13.660.2% of the yeast cells expressing S129A aSyn-
GFP were PI positive, compared to only 2.160.2% or 2.660.5%
of cells expressing WT or S129E aSyn-GFP, respectively
(Figure 1B). Nonetheless, cells expressing S129A aSyn-GFP were
able to adapt and to recover growth ,7.5 hours after expression
induction, with a similar growth rate to those expressing WT or
S129E aSyn-GFP (Figure 1A and S1A). These results suggest that
yeast cells have mechanisms that allow them to cope with and
to recover from toxicity induced by S129A aSyn. Still, cells
expressing the mutant S129A aSyn-GFP failed to reach a final OD
equivalent to that observed for cells expressing WT or S129E
aSyn-GFP (Figure 1A). Altogether, these results demonstrate that
expression of S129A aSyn is more toxic for yeast cells than
expression of WT or S129E aSyn.
We then assessed the correlation between cytotoxicity and the
subcellular distribution of aSyn-GFP. It was previously described
that, initially, aSyn associates with the plasma membrane [16].
Upon increased accumulation of the protein, fluorescent foci
appear adjacent to the plasma membrane and, finally, become
cytoplasmic inclusions [16,27,41]. We imaged cells expressing the
WT, S129A or S129E forms of aSyn-GFP by fluorescence
microscopy and counted the percentage of cells displaying
inclusions at different times after aSyn expression induction (1.5,
3 and 6 hours) (Figure 2A). Interestingly, in addition to being the
Author Summary
Protein aggregation is a common hallmark in neurode-
generative disorders, but is also associated with pheno-
typic plasticity in a variety of organisms, including yeasts.
Alpha-synuclein (aSyn) forms aggregates that are typical of
synucleinopathies, and is phosphorylated at S129, but the
significance of phosphorylation in the biology and
pathophysiology of the protein is still controversial.
Exploring the power of budding yeast, we found phos-
phorylation reduced aSyn toxicity and inclusion formation.
While inclusions formed by WT aSyn were homogeneous,
those formed by S129A aSyn were larger and heteroge-
neous. Interestingly, clearance of aSyn inclusions was
reduced in cells expressing S129A aSyn, correlating with
deficient autophagy activation. The finding that phos-
phorylation alters the ability of cells to clear aSyn
inclusions provides novel insight into the role phosphor-
ylation may have in synucleinopathies, and suggests
posttranslational modifications might constitute switches
cells use to control the aggregation and clearance of key
proteins, opening novel avenues for the development of
therapeutic strategies for these devastating disorders.
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Table 1. Strains used in this study.
Description Reference
W303-1A MATa; can1-100; his3-11,15; leu2-3,112; trp1-1; ura3-1; ade2-1 [95]
W303-1B MATa; can1-100;his3-11, 15; leu2-3, 112; trp1-1; ura3-1; ade2-1 [95]
VSY71 W303-1A trp1-1::pRS304 TRP1+; ura3-1:: pRS306 URA3+ [96]
VSY72 W303-1A trp1-1:: pRS304 GAL1pr-SNCA(WT)-GFP TRP1+; ura3-1:: pRS306 pRS306GAL1pr-SNCA(WT)-GFP::URA3+ [96]
VSY73 W303-1A trp1-1:: pRS304 GAL1pr-SNCA(S129A)-GFP TRP1+; ura3-1:: pRS306 GAL1pr-SNCA(S129A)-GFP::URA3+ [96]
VSY74 W303-1A trp1-1:: pRS304 GAL1pr-SNCA(S129E)-GFP TRP1+; ura3-1:: pRS306 pRS306GAL1pr-SNCA(S129E)-GFP::URA3+ [96]
aSyn S129G W303 trp1-1:: pRS304 GAL1pr-SNCA(S129G)-GFP TRP1+; ura3-1:: pRS306 pRS306 GAL1pr-SNCA(S129G)-GFP::URA3+ This study
VSY71Dpdr5 VSY71 PDR5::KanMX4 This study
VSY72Dpdr5 VSY72 PDR5::KanMX4 This study
VSY73Dpdr5 VSY73 PDR5::KanMX4 This study
VSY71Datg1 VSY71 ATG1::KanMX4 This study
VSY72Datg1 VSY72 ATG1::KanMX4 This study
VSY73Datg1 VSY73 ATG1::KanMX4 This study
VSY71Datg7 VSY71 ATG7::KanMX4 This study
VSY72Datg7 VSY72 ATG7::KanMX4 This study
VSY73Datg7 VSY73 ATG7::KanMX4 This study
VSY71 mCherry-Atg8 VSY71 leu2-3::p305 pATG8 2XmCherry-ATG8 LEU2+ This study
VSY72 mCherry-Atg8 VSY72 leu2-3::p305 pATG8 2XmCherry-ATG8 LEU2+ This study
VSY73 mCherry-Atg8 VSY73 leu2-3::p305 pATG8 2XmCherry-ATG8 LEU2+ This study
VSY71 Pup1-RFP VSY71 PUP1:: p305PUP1-RFP LEU2+ This study
VSY72 Pup1-RFP VSY72 PUP1:: p305PUP1-RFP LEU2+ This study
VSY73 Pup1-RFP VSY73 PUP1:: p305PUP1-RFP LEU2+ This study
VSY71 Bre5 VSY71 pAG303GPD BRE5 HIS3+ This study
VSY72 Bre5 VSY72 pAG303GPD BRE5 HIS3+ This study
VSY73 Bre5 VSY73 pAG303GPD BRE5 HIS3+ This study
VSY71 Ypt1 VSY71 pAG305GPD YPT1 LEU2+ This study
VSY72 Ypt1 VSY72 pAG305GPD YPT1 LEU2+ This study
VSY73 Ypt1 VSY73 pAG305GPD YPT1 LEU2+ This study
VSY71 Ykt6 VSY71 pAG305GPD YKT6 LEU2+ This study
VSY72 Ykt6 VSY72 pAG305GPD YKT6 LEU2+ This study
VSY73 Ykt6 VSY73 pAG305GPD YKT6 LEU2+ This study
VSY71 Ubp3 VSY71 pAG305GPD UBP3 LEU2+ This study
VSY72 Ubp3 VSY72 pAG305GPD UBP3 LEU2+ This study
VSY73 Ubp3 VSY73 pAG305GPD UBP3 LEU2+ This study
VSY71 Gyp8 VSY71 pAG305GPD GYP8 LEU2+ This study
VSY72 Gyp8 VSY72 pAG305GPD GYP8 LEU2+ This study
VSY73 Gyp8 VSY73 pAG305GPD GYP8 LEU2+ This study
VSY71 Pmr1 VSY71 pAG305GPD PMR1 LEU2+ This study
VSY72 Pmr1 VSY72 pAG305GPD PMR1 LEU2+ This study
VSY73 Pmr1 VSY73 pAG305GPD PMR1 LEU2+ This study
VSY71 Dcp1-DsRed VSY71 pAG305GPD DCP1-DsRed LEU2+ This study
VSY72 Dcp1-DsRed VSY72 pAG305GPD DCP1-DsRed LEU2+ This study
VSY73 Dcp1-DsRed VSY73 pAG305GPD DCP1-DsRed LEU2+ This study
VSY71 Cerulean-Ypt1 VSY71 pAG305GPD Cerulean-YPT1 LEU2+ This study
VSY72 Cerulean-Ypt1 VSY72 pAG305GPD Cerulean-YPT1 LEU2+ This study
VSY73 Cerulean-Ypt1 VSY73 pAG305GPD Cerulean-YPT1 LEU2+ This study
VSY71 Cerulean-Ypt31 VSY71 pAG305GPD Cerulean-YPT31 LEU2+ This study
VSY72 Cerulean-Ypt31 VSY72 pAG305GPD Cerulean-YPT31 LEU2+ This study
VSY73 Cerulean-Ypt31 VSY73 pAG305GPD Cerulean-YPT31 LEU2+ This study
VSY71 Cerulean-Sec4 VSY71 pAG305GPD Cerulean-SEC4 LEU2+ This study
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most toxic, the S129A mutant accelerated inclusion formation.
At 3 hours post induction, the percentage of cells displaying
inclusions was 3-fold higher for cells expressing the S129A mutant
when compared to cells expressing WT protein (63.561.8% com-
paring to 23.765.8%) (Figure 2A). After 6 hours of expression
induction almost all cells expressing S129A displayed inclusions
(9860.8%). In turn, the S129E mutation did not significantly
affect the formation of aSyn-GFP inclusions (Figure 2A).
To confirm the effects observed with the S129A mutant were due
to the inability of the protein for being phosphorylated, and not due
to structural differences induced by the alanine residue, we also
tested an aSyn mutant carrying an S129G substitution. Importantly,
the results were identical to those observed with S129A aSyn-GFP
(Figure S2). Thus, for subsequent experiments, we continued using
the S129A aSyn-GFP phospho-resistant mutant.
We next assessed whether the differences in toxicity and inclusion
formation were due to different expression levels of the different
variants of aSyn-GFP tested. Using western blot analyses, we found
all variants were expressed at similar levels after 6 hours of expression
induction (Figure 2B). By using an antibody that specifically
recognizes pS129-aSyn, we observed that human aSyn was
phosphorylated on S129 residue by endogenous kinases (Figure 2B).
Thus, together with the fact that expression of both S129E and WT
aSyn-GFP resulted in similar yeast growth phenotypes and
percentage of cells with aSyn-GFP inclusions, we concluded that,
in our yeast model, the S129E mutation mimics the phosphorylated
state of aSyn at S129 (Figure 1 and 2A). For this reason, we
continued our study using just WT and S129A aSyn-GFP.
In order to determine the biochemical state of WT and
S129A aSyn-GFP we performed centrifugation in sucrose
gradients, 6 hours after aSyn expression induction. We found
that S129A aSyn-GFP is enriched in fractions corresponding to
higher molecular weight species (.200 kDa) (Figure 2C, left
panel), and these differences were not due to differences in total
protein levels (Figure 2C, right panel).
To further confirm this, we performed size exclusion chroma-
tography (SEC), another widely established method for the
biochemical characterization of protein species. For WT aSyn-
GFP, we detected species in fractions corresponding to molecular
weights of 440 kDa (Figure 2D and S3). Interestingly, for S129A
aSyn-GFP, we detected species in fractions corresponding to even
higher molecular weights, since these eluted in the void volume of
the column (Figure 2D and S3). The distribution of pS129 aSyn-
GFP was also analyzed and showed a similar distribution to that of
WT aSyn-GFP (Figure 2D). This result convincingly demon-
strates, for the first time, that in the yeast model considerable large
oligomeric species of aSyn-GFP are formed, an issue that had not
been previously resolved in the field.
Modulation of aSyn S129A toxicity by modifiers of ER-to-
Golgi trafficking defects
Several studies demonstrated that aSyn may disrupt multiple
intracellular trafficking pathways in yeast [16,17,20,26-28,42,43].
However, the endoplasmic reticulum (ER)-to-Golgi vesicular
trafficking impairment is one of the first defects following in-
duction of aSyn expression [28]. This defect can be rescued by
genes promoting ER-to-Golgi trafficking. In addition, genes
negatively regulating ER-to-Golgi trafficking enhance aSyn
toxicity [28]. To determine if the increased toxicity observed by
the blockade of aSyn phosphorylation was also associated with ER-
to-Golgi trafficking defects, we tested the effects of previously
described suppressors (Ypt1, Ykt6, Ubp3, and Bre5) and enhancers
(Gyp8 and Pmr1) of aSyn toxicity in yeast. These modifiers of aSyn
toxicity were co-expressed with either WT or S129A aSyn-GFP and
the effect on toxicity and inclusion formation was evaluated 6 hours
after induction (Figures 3 and 4). As in our yeast model WT aSyn-
GFP is moderately toxic, the suppression of toxicity was not
remarkable in the spotting assay but became evident when cells
were assessed for PI-staining, a more refined method to determine
cell viability (Figure 3). Our findings were consistent with what was
previously described [28]. Among the suppressors tested, only Bre5
was not able to rescue S129A aSyn-GFP toxicity in both assays
(Figure 3). Expression of Ypt1, Ykt6 and Ubp3 significantly reduced
the formation of both WT and S129A aSyn-GFP inclusions
(Figure 4A) while the overexpression of Bre5 only decreased the
formation of WT aSyn-GFP inclusions, and had no effect on S129A
inclusion formation (Figure 4A).
Regarding the two enhancers of aSyn toxicity, Gyp8 and Pmr1,
expression of an extra copy of these genes exacerbated WT aSyn
toxicity as expected [28], and had a similar effect on S129A aSyn
Table 1. Cont.
Description Reference
VSY72 Cerulean- Sec4 VSY72 pAG305GPD Cerulean-SEC4 LEU2+ This study
VSY73 Cerulean- Sec4 VSY73 pAG305GPD Cerulean-SEC4 LEU2+ This study
VSY71 Cerulean-Ypt6 VSY71 pAG305GPD Cerulean-YPT6 LEU2+ This study
VSY72 Cerulean-Ypt6 VSY72 pAG305GPD Cerulean-YPT6 LEU2+ This study
VSY73 Cerulean-Ypt6 VSY73 pAG305GPD Cerulean-YPT6 LEU2+ This study
VSY71 Cerulean-Vps21 VSY71 pAG305GPD Cerulean- VPS21 LEU2+ This study
VSY72 Cerulean-Vps21 VSY72 pAG305GPD Cerulean- VPS21 LEU2+ This study
VSY73 Cerulean-Vps21 VSY73 pAG305GPD Cerulean- VPS21 LEU2+ This study
VSY71 Cerulean-Ypt52 VSY71 pAG305GPD Cerulean-YPT52 LEU2+ This study
VSY72 Cerulean-Ypt52 VSY72 pAG305GPD Cerulean-YPT52 LEU2+ This study
VSY73 Cerulean-Ypt52 VSY73 pAG305GPD Cerulean-YPT52 LEU2+ This study
VSY71 Cerulean-Ypt7 VSY71 pAG305GPD Cerulean-YPT7 LEU2+ This study
VSY72 Cerulean-Ypt7 VSY72 pAG305GPD Cerulean-YPT7 LEU2+ This study
VSY73 Cerulean-Ypt7 VSY73 pAG305GPD Cerulean-YPT7 LEU2+ This study
doi:10.1371/journal.pgen.1004302.t001
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(Figure 3). Gyp8 and Pmr1 also increased the formation of aSyn
inclusions in WT aSyn-GFP expressing cells without affecting the
percentage of cells with S129A aSyn-GFP inclusions, which is
already high and therefore precludes the ability to detect an
additional increase (Figure 4A).
To determine if the phenotypes observed resulted from an effect
of the modifiers on the levels of WT and S129A aSyn-GFP, we
preformed western blot analyses. We found that total aSyn and
pS129 levels were not affected by the co-expression of the
modifiers (Figure 4B).
Altogether, these results indicate that ER-to-Golgi vesicle
trafficking defects associated with S129A aSyn toxicity can also
be rescued by suppressors of WT aSyn toxicity.
Blockade of aSyn phosphorylation compromises its
degradation
We postulated that the different biochemical properties
might arise from differences in protein clearance of the S129A
aSyn-GFP. To test this, aSyn expression was stopped after 6 hours
by replacing galactose by glucose (to repress the GAL1 promoter)
and aSyn-GFP clearance was followed for 6 hours (Figure 5A). We
found 4960.4% of cells expressing S129A aSyn-GFP contained
inclusions, while only 861.2% of the ones expressing the WT form
presented aSyn-GFP inclusions, after the clearance period
(Figure 5B and C). This corresponds to a reduction of about
50% and 70% when compared to the initial amount of cells with
inclusions, respectively (Figure 5C). At 0 hours of clearance
(6 hours after aSyn expression induction), S129A expressing cells
presented fewer inclusions per cell (Figure 5D). These inclusions
were larger and more heterogeneous in size than those formed by
WT aSyn-GFP (Figure 5E). After 6 hours of clearance, no
significant differences in the size of the inclusions formed by WT
or S129A aSyn-GFP were detected (Figure 5E), due to an increase
in size of the inclusions formed by WT aSyn-GFP compared to
zero of clearance (Figure 5E).
To further investigate how phosphorylation affects aSyn inclusion
formation and characteristics, cells were analysed by flow cytometry
(Figure 5F). At 0 hours of clearance, both strains presented a
homogeneous distribution of the GFP fluorescence showing a single
population of cells (Figure 5F). However, after 6 hours of clearance,
two populations were visible for both WT and S129A aSyn-GFP,
one with weaker (sub-population a) and one with stronger GFP (sub-
population b) signal (Figure 5F). We found that the strain expressing
S129A aSyn-GFP accumulated more cells in the population
displaying stronger GFP signal (1163.5% versus 1.461.0% for
WT aSyn-GFP). Together with the results from the fluorescent
microscopy, these findings are consistent with cells accumulating
inclusions of different sizes, with the larger inclusions displaying
stronger GFP signal (Figure 5F).
Next, we evaluated the protein levels of S129A and WT aSyn-
GFP at 0 and 6 hours of clearance by western blot analyses. As
expected from the results in Figure 2C, no differences were observed
at 0 hours of clearance (Figure 6A). In addition, at 0 hours of
clearance, both WT and S129A aSyn-expressing cells presented
similar levels of Triton-X-Insoluble protein (TI), 55.3762.23% and
50.6969.47%, respectively (Figure 6B). However, 6 hours after
clearance, the levels of WT aSyn-GFP (41.9366.04%) were around
32% below those of S129A aSyn-GFP (73.01619.45%) (Figure 6B),
and this was accompanied by a significant increase of the S129A
aSyn-GFP in the TI fraction (69.9866.11%) (Figure 6B). Impor-
tantly, during the clearance period, the levels of pS129 aSyn did not
change significantly for the WT aSyn-expressing strain (Figure S4).
Figure 1. S129A aSyn is more toxic for yeast cells than the WT aSyn. (A) Growth curve based on culture OD600nm of yeast cells expressing WT
(%), S129A (m) or S129E (#) aSyn-GFP, compared to cells that are not expressing the human protein (e). Cells used as inoculum were exponential-
phase cells cultivated in raffinose medium that at time zero were transferred to galactose medium to induce aSyn-GFP expression. (B) aSyn-GFP
versus Propidium Iodide (PI) fluorescence and Frequency of PI and GFP positive cells assessed by flow cytometry, in the indicated yeast cells, after
6 hours of aSyn expression induction (***p,0.001; one way ANOVA with Bonferroni’s multiple comparison test). A representative result is shown
from at least five independent experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g001
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S129 phosphorylation modulates aSyn dynamics in
inclusions
Based on the morphological and biochemical differences
observed for inclusions formed by WT or S129A aSyn-GFP, we
hypothesized that the dynamics of aSyn in the inclusions might
differ. To test this, we first used high-resolution 4D imaging in WT
and S129A aSyn-expressing cells. Images were acquired every
10 min for 18 hours after induction of aSyn expression (Figure 7
and Supplementary Movie S1 and S2). Initially, WT aSyn-GFP
distributed preferentially along the plasma membrane. In contrast,
S129A aSyn-GFP formed inclusions sooner than the WT aSyn-
GFP (Figure 7). The percentage of cells with inclusions in the
population of cells expressing WT or S129A aSyn-GFP was
Figure 2. S129A aSyn forms more inclusions and oligomeric species with higher molecular weight than the WT form. (A) Intracellular
localization of the WT, S129A or S129E aSyn-GFP (left panel) and percentage of yeast cells containing aSyn-GFP inclusions (right panel), assessed by
fluorescence microscopy at the indicated time points after aSyn-GFP expression induction (***p,0.001; one way ANOVA with Bonferroni’s multiple
comparison test). (B) WT, S129A or S129E aSyn-GFP expression and pS129 levels in yeast cells assessed by western blot analysis of total protein
extracts, at the indicated time points after aSyn-GFP expression induction (left panel). Densitometric analysis of the immunodetection of aSyn-GFP
relative to the intensity obtained for GAPDH, used as loading control, presented in arbitrary units (a.u.) (right panel). Results shown are from one
representative experiment from a total of three independent experiments. (C) The aggregated species formed in yeast cells by the WT and S129A
aSyn-GFP were resolved using sucrose gradients after 6 hour of aSyn-GFP expression induction. The resulting fractions were separated on an SDS-
page gel followed by immunoblotting with an antibody against aSyn (left panel). The same amount of WT and S129A aSyn-GFP protein was applied
to the sucrose gradients, as confirmed by western blot (right panel). (D) The aggregated species formed by WT and S129A aSyn-GFP were also
resolved using size exclusion-chromatography (SEC) after 6 hours of aSyn-GFP expression induction. Fractions were collected and separated on SDS-
PAGE followed by western blot analyses with an antibody against aSyn or pS129 aSyn. The molecular weights indicated correspond to the calibration
curve performed in the SEC, as shown in Figure S3. A representative result is shown from at least three independent experiments. Values represent
the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g002
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determined and the results confirm that S129A mutation in aSyn
promotes inclusions formation in yeast (Figure 7B).
To further compare the protein dynamics in the inclusions
formed by WT or S129A aSyn-GFP, we next used Fluorescence
Recovery After Photobleaching (FRAP) and calculated kinetic
parameters based on exponential fitting to the FRAP plots
(Figure 8). Under the assumption that aSyn-GFP diffusion is very
fast compared both to binding and to the timescale of the FRAP
Figure 3. ER-to-Golgi trafficking genes are modifiers of S129A aSyn toxicity. (A) aSyn-GFP versus Propidium Iodide (PI) fluorescence and
Frequency of PI positive cells assessed by flow cytometry 6 hours after aSyn expression induction (111p,0.001 vs empty strain; *** p,0.001 vs WT;
###,0.001 or #p,0.05 vs S129A; one way ANOVA with Bonferroni’s multiple comparison test). Results shown are from one representative
experiment from three independent experiments. Values represent the mean 6 SD. (B) Spotting assay of the indicated yeast cells. Cell suspensions
were adjusted to the same OD600nm, serially diluted and spotted onto the surface of the solid medium containing either glucose (control) or galactose
(induced aSyn expression) as carbon source. A representative result is shown from at least three independent experiments.
doi:10.1371/journal.pgen.1004302.g003
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experiment, i.e. that binding dominates and diffusion is not
detected in the FRAP recovery, an exponential fit to each FRAP
recovery curve enables the determination of the aSyn-GFP
immobile fraction (IF) and mean residence time (T) (Figure
S5A). After 6 hours of aSyn expression induction, the inclusions
formed by the WT aSyn-GFP were homogeneous with respect to
the relative fluorescence recovery profile (Figure 8A). The
residence time for these inclusions was 39.360.7 seconds and
the immobile fraction, which corresponds to static or long-term
bound aSyn-GFP, was 19.367.9% (Figure S5A). In contrast, the
inclusions formed in cells expressing S129A aSyn-GFP were
heterogeneous, and could be distinguished in three main groups,
based on their FRAP recovery profiles. In group I the immobile
fraction was 55.767.5% and the mean residence time was
17.260.8 seconds. In group II, the inclusions behaved as the
ones formed in cells expressing WT aSyn-GFP, with a mean
residence time of 35.2611.9 seconds and an immobile fraction of
24.1612.4%. Finally, in group III, inclusions presented a lower
Figure 4. Modulation of ER-to-Golgi trafficking alters S129A aSyn inclusion formation. (A) Intracellular localization of the WT or S129A
aSyn-GFP (left panel) and percentage of yeast cells containing aSyn-GFP inclusions (right panel) in the indicated yeast strains, assessed by
fluorescence microscopy after 6 hours of aSyn-GFP expression induction (*** p,0.001 vs WT; ###,0.001 vs S129A; one way ANOVA with
Bonferroni’s multiple comparison test). (B) WT or S129A aSyn-GFP expression and pS129 levels in the indicated yeast strains assessed by western blot
analysis of total protein extracts 6 hours after aSyn-GFP expression induction. A representative result is shown from at least three independent
experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g004
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mean residence time of 14.963.1 seconds and an immobile
fraction of 12.767.0%. We next determined the mean area and
fluorescence intensity of the inclusions analyzed in the FRAP
experiments before photobleaching. Inclusions formed by
S129A aSyn-GFP were in general larger and presented stronger
fluorescence than those formed by WT aSyn-GFP, suggesting the
existence of heterogeneity in the inclusions (Figure 8B and C). To
test whether inclusion heterogeneity was associated with reduced
viability of cells expressing non-phosphorylatable S129A aSyn, we
performed FRAP only in PI positive cells containing inclusions. In
those cells, the initial fluorescence of the inclusions was not
recovered at all and the fluorescence signal was unstable (Figure
S6), in contrast to the patterns observed for the WT and S129A
inclusions presented in Figure 8. Next, we compared protein
dynamics of S129A aSyn-GFP inclusions 6 hours after blocking
aSyn expression with that of inclusions at 0 hours of clearance.
Again, we distinguished three types of inclusions based on the
protein dynamics profiles (Figure 8A). However, after 6 hours of
Figure 5. S129A aSyn inclusions clearance is compromised. (A) Schematic representation of the treatments performed: aSyn expression was
induced for 6 hours in galactose medium (Gal) and then yeast cells were transferred to glucose medium (Glu) to repress aSyn expression for 6 hours.
(B) Intracellular localization of WT or S129A aSyn-GFP and (C) percentage of yeast cells containing aSyn-GFP inclusions, assessed by fluorescence
microscopy at the indicated time points of aSyn clearance (***p,0.001, **p,0.01; two-tailed unpaired t-test with Welch’s correction). (D) Percentage
of cells presenting 3 or less inclusions, or 4 or more inclusions per cell (**p,0.01, *p,0.05; Unpaired two-tailed t-test), and (E) inclusions size (mm2) at
0 or 6 hours of aSyn clearance. (F) SSC (side scatter) and aSyn-GFP fluorescence in the indicated yeast cells, assessed by flow cytometry, at 0 and
6 hours after aSyn clearance. A sub-population of yeast cells presenting higher levels of GFP fluorescence is distinguishable after 6 hours of WT or
S129A aSyn clearance (left panel). The frequency of cells of this sub-population is represented the in right upper panel. In the right lower panel a
fluorescence microscopy picture exemplifies the different GFP intensities observed in aSyn yeast cells after 6 hours of clearance [(a) indicates cells
with lower levels of GFP fluorescence and (b) sub-population of yeast cells presenting higher levels of GFP fluorescence]. A representative result is
shown from at least three independent experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g005
Figure 6. The percentage of Triton-X insoluble S129A aSyn increases during clearance. (A) WT and S129A aSyn-GFP protein levels in yeast
cells assessed by western blot analysis of total protein extracts at the indicated time points of aSyn-GFP clearance (left panel). Densitometric analysis
of the immunodetection of aSyn relative to the intensity obtained for GAPDH, used as loading control, presented in arbitrary units (a.u.) (right panel)
(***p,0.001, *p,0.05; one way ANOVA with Bonferroni’s multiple comparison test). (B) Triton-X soluble (TS) and Triton-X insoluble (TI) fractions of
aSyn WT or S129A assessed by western blot analysis (upper panel) and determination by densitometric analysis of the percentage of TI aSyn, at the
indicated time points of aSyn clearance (lower panel) (*p,0.05; Mann-Whitney test). GAPDH was used as an internal control for the experiment. A
representative result is shown from at least four independent experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g006
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clearance, the immobile fraction as well as the mean residence
time increased in the S129A aSyn-GFP inclusions when compared
to 0 hours (Figure S5B).
The presence of inclusions with different aSyn-GFP dynamics in
the cell led us to hypothesize that the protein was partitioning
between distinct subcellular protein quality control compartments.
In particular, we hypothesized these compartments might be
either the ‘‘juxtanuclear quality control’’ compartment (JUNQ),
that is in close proximity to the nucleus and colocalizes with the
proteasome, the ‘‘insoluble protein deposit’’ (IPOD), that coloca-
lizes with the autophagic marker Atg8 [44], or P-bodies,
cytoplasmic RNA-protein (RNP) granules that contain non-
translating mRNAs as a cellular response to stress [45]. To verify
these hypotheses, we performed fluorescence microscopy using
established sub-cellular markers, namely Atg8 (IPOD), Pup1 (the
beta 2 subunit of the 20S proteasome, JUNQ) and Dcp1 (P-
Bodies). However, we observed no colocalization between WT or
S129A aSyn-GFP with any of these markers (Figure S7).
aSyn inclusions in yeast cells colocalize with diverse trafficking
markers including Ypt1 (ER-to-Golgi), Ypt31 (late Golgi), Sec4
(secretory vesicles-to-PM), Ypt6 (endosome-to-Golgi), Vps21 and
Ypt52 (early-to-late endosome) and Ypt7 (LE-to-vacuole) [27].
Considering that we observed that S129A aSyn also relates to
defects in ER-to-Golgi trafficking, we asked whether blocking
pS129 could alter the normal distribution of aSyn inclusions.
Thus, we compared the colocalization of WT and S129A aSyn-
GFP inclusions using the trafficking markers indicated above. We
found that blocking pS129 did not significantly alter the
localization of aSyn inclusions (Figure S8).
aSyn has previously been shown to interact with membranes
and, at low levels of WT aSyn expression, it localizes mostly to the
plasma membrane [16]. Since aSyn also begins to aggregate at the
membrane in small vesicles, we sought to investigate its association
with the endocytic machinery. In order to visualize plasma
membrane to vacuole endocytic trafficking, we used the
monocarboxylate-proton symporter Jen1, which undergoes inter-
nalization through the endocytic pathway with subsequent
vacuolar degradation [46,47]. At the initial stages of aSyn
inclusion formation we observed almost exclusive colocalization
of WT and S129A aSyn-GFP inclusions with Jen1, from the
plasma membrane, in early endocytic vesicles, to the vacuole
(Figure 9 and Supplementary Movie S3 and S4). As aSyn inclusion
formation becomes more severe, the vesicles no longer reach the
vacuole and accumulate in larger Jen1-positive inclusions, which
are likely to be late endosomes (Figure 9). WT aSyn inclusions are
present either as single vesicle or smaller clusters, while S129A
aSyn inclusions at late stages of aggregation represent large
clusters of vesicles (Figure 9).
Unphosphorylatable aSyn impairs induction of
autophagy
Next, we evaluated whether phosphorylation altered the
clearance of aSyn in the cell. First, we tested protein degradation
by the ubiquitin-proteasome system (UPS). For this, we deleted the
PDR5 gene in the strains expressing aSyn-GFP to ensure chemical
inhibition of the proteasome by MG132 [48]. The expression
levels of aSyn-GFP in the Dpdr5 mutants and in the original strains
were similar (Figure S9A). Western blot analysis revealed a marked
increase in the levels of ubiquitinated proteins in MG132 treated
cells, confirming pharmacological proteasome inhibition was
achieved (Figure S9B). However, we found that proteasome
inhibition did not alter the levels of either WT or S129A aSyn-
GFP, nor the percentage of cells displaying aSyn inclusions (Figure
S9C). We observed a striking increment in ubiquitinated pro-
teins relative to 3 hours of aSyn clearance (Figure S9B), suggesting
the aSyn-induced proteasome inhibition was at least partially
reversible.
Afterwards, we analyzed the contribution of autophagy to the
clearance of WT and S129A aSyn-GFP by comparing ATG8
induction and autophagic flux. We used the mCherry-Atg8
Figure 7. Blocking aSyn phosphorylation reduces membrane interactions and accelerates inclusion formation. (A) Time lapse confocal
imaging comparing the distribution of WT or S129A aSyn-GFP at the indicated time points after induction of aSyn expression. Nuclei were visualized
by co-expressing NLS-TagRFP657. (B) Percentage of WT and S129A aSyn-GFP expressing cells presenting inclusions over time. nwt = 48 cells,
nS129A = 55 cells. Inclusions were recognized by measuring GFP intensity.
doi:10.1371/journal.pgen.1004302.g007
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processing assay [49,50], and inserted the reporter under the
control of the endogenous ATG8 promoter in the genome of the
strains expressing WT or S129A aSyn-GFP (Table 1). ATG8
induction was measured by quantifying the increase of total
mCherry signal (mCherry-Atg8 and free mCherry signal)
normalized to the loading control (GAPDH) (Figure 10A),
reflecting autophagy induction [49,50]. On the other hand,
autophagic flux was quantified by measuring the vacuolar
degradation of the Atg8 domain of the reporter (ratio of free
mCherry to total mCherry signal) by western blot analysis
[49,50], reflecting the vacuolar transfer and degradation of
autophagosomes (Figure 10A). Interestingly, WT aSyn-GFP
induced a 2-fold increase in the levels of Atg8 which decreased
gradually during the clearance period (Figure 10A). In contrast,
the levels of Atg8 remained unaltered throughout induction and
clearance in cells expressing S129A aSyn-GFP (Figure 10A). No
alterations in autophagic flux were observed with either WT or
S129A aSyn-GFP.
Using flow cytometry, we confirmed these results and
established a correlation between autophagy induction
(measured by mCherry fluorescence intensity) and aSyn-GFP
signal (Figure 10B). At 0 hours of clearance the mCherry-Atg8
median fluorescence intensity (MFI) in cells expressing S129A
aSyn-GFP were considerable higher than those in cells expressing
WT aSyn, and decreased gradually during the clearance period
to near basal levels (Figure 10B). These results are consistent with
the western blot analysis described above (Figure 10A). As
expected, it was visible that, during clearance, the fluorescence of
either WT or S129A aSyn-GFP decreases (Figure 10B). However,
in both cases a sub-population of cells with larger and brighter
inclusions maintained stronger GFP fluorescence after 6 hours of
clearance. In this sub-population, higher levels of mCherry-Atg8
were observed both in the cells expressing WT or S129A aSyn-
GFP, indicating that autophagy induction is more pronounced in
cells with bigger and brighter aSyn inclusions (Figure 10B).
However, in this sub-population, the cells expressing S129A
Figure 8. Inclusions formed by S129A aSyn-GFP are more heterogeneous than the ones formed by WT aSyn-GFP. (A) FRAP recovery
curves for WT and S129A aSyn-GFP inclusions on yeast cells expressing aSyn forms at the indicated time points. For each strain, at least 15 inclusions
in different cells were analyzed. Each plot represents mean 6 SD for each time point for all FRAP experiments (for the WT aSyn-GFP expressing cells)
or groups of FRAP experiments organized by recovery profiles (for the S129A aSyn-GFP expressing cells). (B) FRAP time lapse recording of a
representative inclusion of each group (C) Area (pixels) and fluorescence intensity mean (in arbitrary units, a.u.) of the inclusions analyzed (***p,
0.001 and ** p,0.01; one way ANOVA with Bonferroni’s multiple comparison test). A representative result is shown from at least three independent
experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g008
Phosphorylation Modulates aSyn Clearance in Yeast
PLOS Genetics | www.plosgenetics.org 12 May 2014 | Volume 10 | Issue 5 | e1004302
aSyn-GFP displayed lower levels of mCherry-Atg8 than cells
expressing WT aSyn-GFP both at 0 and 6 hours of clearance
(Figure 10B).
A second line of evidence for the effect of pS129 on aSyn
clearance by autophagy was obtained by genetically modulating this
pathway. For these studies, we deleted ATG1 and ATG7 genes in the
WT and S129A aSyn-expressing strains. Atg1 is a kinase playing an
important role in autophagy initiation [51] and its mutant is
defective in autophagy [52] while Atg7 is an activator of Atg8 and is
required for the formation of autophagic bodies [53]. Deletion of
ATG1 and ATG7 did not significantly affect WT or S129A aSyn-
GFP expression levels after 6 hours of induction (Figure 11A).
However, when aSyn expression was turned off and clearance was
followed during 18 hours, Datg7 resulted in higher levels of WT and
S129A aSyn-GFP (Figure 11A). Deletion of ATG1 and ATG7
significantly increased WT aSyn pS129 levels after 0 hours of
clearance (6 hours after aSyn expression induction), an effect that
was not observed after 6 hours of clearance (Figure S10).
Deletion of ATG1 and ATG7 also significantly increased the
percentage of cells displaying aSyn inclusions after 6 hours of
clearance (Figure 11B). Flow cytometry experiments confirmed the
fluorescence microscopy results, showing a significant increase in
the population of cells displaying stronger GFP signal when
autophagy was impaired due to ATG1 or ATG7 deletion
(Figure 11C). Moreover, Datg1 and Datg7 S129A aSyn-GFP
expressing cells also exhibited a higher percentage of PI positive
cells, indicating that impairment of autophagy increased S129A
aSyn-GFP toxicity, an effect that was not observed for WT aSyn-
GFP expressing cells (Figure 11D).
Altogether these results indicate that blocking aSyn phosphor-
ylation impacts on autophagy induction, suggesting cells process
phosphorylated aSyn in a distinct way.
Figure 9. Plasma membrane to vacuole endocytic trafficking of WT and S129A aSyn. (A) aSyn inclusions localize to membrane and
endosomal compartments. Cells coexpressing Jen1-mCherry and WT or S129A aSyn-GFP were grown at 30uC in glucose and shifted to galactose for
6 hours. Jen1-mCherry is constitutively synthesized, trafficked to the membrane, and re-absorbed through the endocytic pathway, eventually ending
up in the vacuole. Since mCherry is pH stable it is visible in the vacuole. aSyn-GFP inclusions colocalize with Jen1-mCherry in endosome
compartments throughout the entire endocytic pathway. (B) aSyn foci cluster with vesicles. Images shown are still frames from a time-lapse series
showing internalization of aSyn through the endocytic pathway. In some cases of low level of aSyn aggregation enters the vacuole. As the
aggregation level increases, however, aSyn-cotaining vesicles are trapped, likely in late endosomes. (C) aSyn inclusions are present as vesicles or
vesicle clusters (arrows). Expression of S129A aSyn-GFP was induced for 8 hours. 3D reconstruction and single z sections (2D) are shown. Each z series
was acquired with 0.4 micron step size and 21 total steps.
doi:10.1371/journal.pgen.1004302.g009
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Discussion
Here, we found that WT aSyn-GFP is strongly phosphorylated
at S129 by endogenous yeast kinases and S129E mutant aSyn-
GFP mimics the behavior of WT protein, in particular with
respect to cytotoxicity and inclusion formation. This contrasts with
other reports that showed the S129E aSyn-GFP mutant fails to
mimic the effect of aSyn S129 phosphorylation [54,55]. It is
possible that the discrepancy is due to differences in the systems
used but, importantly, it suggests S129E aSyn mutant might
constitute a valid approach for the assessment of the cellular
responses involved in the accumulation of phosphorylated aSyn.
The S129A mutation was found to promote aSyn fibrillization
[10,56]. However, this was not consensual in all cell and animal
models where S129A was expressed. In SH-SY5Y cells, a
neuroblastoma cell line with dopaminergic characteristics,
S129A aSyn expression reduces inclusion formation [12], while
in a Drosophila model, S129A aSyn expression results in the
accumulation of increased levels of aSyn oligomers, but not of
mature fibrils [7]. In our yeast model, expression of the
phosphorylation-deficient S129A aSyn-GFP resulted in an exac-
erbation of aSyn toxicity concomitantly with a reduction in
cellular viability and an increase in aSyn inclusion formation. This
phenotype does not appear to be related to specific structural
consequences of this mutation on aSyn, but rather to the blockade
of S129 phosphorylation, as similar results were obtained when
S129G aSyn-GFP, a different aSyn phospho-resistant mutant, was
expressed.
Despite the accumulating evidence favoring the hypothesis that
soluble aSyn oligomers, rather than insoluble protein aggregates,
are the cytotoxic species in PD, the question is still unresolved
[57,58]. In yeast, aSyn inclusions were described as clusters of
vesicles [26,27,42], raising questions about whether aSyn accu-
mulations actually displayed biochemical properties compatible
with the formation of protein aggregates. However, at least some
of these accumulations are indeed amyloid-like and b-sheeted
aggregates, as they react with thioflavin S [41] or thioflavin T [59].
Here, we biochemically characterized the aSyn-GFP species that
are formed in yeast cells using two complementary approaches
(sucrose gradients and size exclusion chromatography) and clearly
demonstrate the formation of large oligomeric species. Moreover,
we established a correlation between increased inclusions forma-
tion and exacerbation of cytotoxicity and the formation of
oligomeric species with higher molecular weight for the S129A
aSyn-GFP mutant. Interestingly, we did not observe differences in
the TX-insoluble fractions of cells expressing wither WT or S129A
mutant aSyn. These results are consistent with other reports where
large aSyn soluble oligomers are also considered to constitute the
toxic species [60].
Among the various cellular defects that have been implicated in
the etiology of synucleinopathies, vesicular trafficking impairment
has emerged as a major component of aSyn-dependent toxicity in
yeast and in other model organisms [16,17,20,26–28,42,43]. Both
genetic and chemical modulation of vesicular trafficking modulate
aSyn toxicity [17,20,28]. In this study we show that pS129 blockade
exacerbates vesicular trafficking defects that can be relieved by
overexpression of YPT1, YKT6 and UBP3, genes that increase
forward transport between ER and Golgi. Ypt1, the Rab guanosine
triphosphatase whose mammalian ortholog Rab1 is able to prevent
dopaminergic neuron loss [28], plays an essential role in the
tethering and docking of the transport vesicle with the Golgi [61].
Ykt6, the soluble NSF (N-ethylmaleimide–sensitive factor) attach-
ment protein receptor protein (SNARE), increases forward trans-
port by increasing the likelihood of membrane vesicles from the ER
tethering to Golgi target membranes [62]. In turn, the ubiquitin
protease Ubp3, together with its cofactor Bre5, function to
deubiquitinate the COPII coat protein Sec23p, and likewise
promote vesicle exit from the ER [63]. Interestingly, the Bre5
cofactor, which also suppresses aSyn toxicity [28], was not able to
restore S129A aSyn-GFP induced trafficking defect. This suggests
that aSyn phosphorylation may modulate the way the protein
interacts with components of the trafficking pathway, as one might
expect.
Moreover, GYP8 and PMR1 whose overproduction nega-
tively regulates ER-Golgi trafficking, exacerbate S129A aSyn-
GFP toxicity. Gyp8, is a negative regulator of Ypt1, that
therefore inhibits ER-to-Golgi trafficking [64], while Pmr1 is
the major Golgi membrane P-type ATPase ion pump
responsible for transporting Ca2+ and Mn2+ ions into the
Golgi apparatus, both of which are important for proper
processing and trafficking of proteins through the secretory
pathway [65].
Proteostasis is a central concept in the context of several disorders
[66]. An imbalance between the rates of protein synthesis,
clearance, and aggregation, caused by proteostasis dysfunction,
could favor accumulation and/or formation of protein oligomers
and inclusions that contribute to cytotoxicity [67]. We found that
blocking aSyn phosphorylation impaired the turnover of aSyn.
During clearance of S129A aSyn, we observed a significant increase
of the TX-insoluble fraction, concomitantly with the attenuation
aSyn-induced cytotoxicity. Our observations are consistent with
those in a study in Drosophila where reduced aSyn toxicity was
correlated with an increase in detergent-insoluble aSyn [68] and
suggests this may constitute a defense mechanism.
Using high-resolution 4D imaging we found that WT aSyn has
a lag phase during which it preferentially associates with the
plasma membrane, whereas the S129A forms inclusions almost
immediately. Furthermore, blocking aSyn phosphorylation alters
the dynamics of aSyn in inclusions suggesting there are distinct
populations of aSyn accumulating with different kinetics in
inclusions. Based on this, we defined three groups of inclusions
based on the recovery after photobleaching.
The presence of an immobile fraction of aSyn is common to all
FRAP recovery curves, albeit at different proportions for each type
Figure 10. S129A aSyn impairs ATG8 induction. (A) Autophagy evaluated by mCherry-Atg8 processing assay in yeast cells expressing mCherry-
Atg8 under the regulation of the endogenous promoter alone (control) or together with either WT or S129A aSyn, at the indicated time points,
assessed by western blot (upper panel) (hi:hours of induction; hc: hours of clearance). ATG8 induction quantified by the total mCherry signal
(mCherry-Atg8 and free mCherry signal, detected with anti-mCherry) (lower left panel); autophagic flux quantified by measuring the vacuolar
degradation of the Atg8 domain reporter (ratio of free mCherry to total mCherry signal) (lower right panel). (***p-value,0.001; one way ANOVA with
Bonferroni’s multiple comparison test). Results shown are from one representative experiment from a total of five independent experiments. (B) aSyn-
GFP and mCherry-Atg8 fluorescence intensity in yeast cells expressing mCherry-Atg8 alone (control) or together with either WT or S129A aSyn, at the
indicated time points, assessed by flow cytometry (upper panel). mCherry-Atg8 MFI from all cells (lower left panel) and from the indicated sub-
population (lower right panel) (***p,0.001, one way ANOVA, with Bonferroni’s multiple comparison test). Yeast cells not expressing aSyn-GFP or
mCherry-Atg8 were also used as an additional control (empty). A representative result is shown from at least four independent experiments. Values
represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g010
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of inclusions. However, blocking aSyn phosphorylation enables the
protein to establish transient interactions with inclusions, which
occur significantly faster than with WT aSyn.
When the synthesis of aggregation-prone proteins surpasses the
degradation capacity of the cell, different quality-control mech-
anisms that are conserved from yeast to mammalian cells actively
sequester aggregated proteins as a protective cellular response
[58]. Misfolded aggregated proteins partition between two
cellular compartments: the JUNQ and the IPOD compartment,
which may serve a protective function and facilitate aggregate
clearance. We postulated that the differences in sizes, number
and dynamics of the inclusion formed by WT and S129A aSyn
might reflect the distribution of aSyn between these compart-
ments where misfolded proteins display distinct relative exchange
rates with the soluble cytosolic pool [44,69,70]. Non-phosphor-
ylated S129A aSyn accumulating in a less mobile fraction could
indicate the protein was localizing to the IPOD, the preferred
destination of protein aggregates. Likewise, the S129A aSyn in
group III indicated the exchange of soluble aSyn with the
cytosolic pool, as described for the JUNQ compartment.
Unexpectedly, we found no colocalization of WT or S129A
aSyn with neither IPOD nor JUNQ, suggesting that aSyn is not
actively sorted to these cellular compartments in yeast. Moreover,
we also did not observe colocalization of WT or S129A aSyn-
GFP with P-bodies. Alternatively, we did detect colocalization of
S129A aSyn-GFP with several vesicular markers including Ypt31
(late Golgi), Sec4 (secretory vesicles-to-PM), Ypt6 (endosome-to-
Golgi), Vps21 and Ypt52 [EE-to-late endosome (LE)] and Ypt7
(LE-to-vacuole).
We observed that initial stages of aSyn inclusion formation
occur in conjunction with receptor-mediated endocytosis of the
plasma membrane symporter Jen1. The alteration in the course of
endocytosis caused by the presence of aSyn in endosomal
compartments affects trafficking, causes accumulation of vesicles
and eventually leads to cell death. The deficiency in the delivery of
late endosomes carrying aSyn to the vacuole is more pronounced
in the strain expressing S129A aSyn. This prompted us to evaluate
the effect of this mutant on endocytosis. The clustering of the
endosomal compartment caused by the presence of aSyn on the
membrane, slows down endocytic trafficking and eventually blocks
internalization of vesicles. While small inclusions of WT and
S129A aSyn are cleared, large clusters of S129A aSyn accumulate
proximally to the vacuole and, with new cycles of endocytosis, the
size of the clusters becomes unbearable for the cell.
Given that early endosome functions are essential for autophagy
and for endocytosis-UPS, deregulation of endocytosis by the
presence of aSyn in vesicles disrupts not only vesicular trafficking
but also major degradation pathways. Vesicles and membranous
structures were also observed to accumulate at the periphery of
LBs in PD brains [26], reinforcing the relevance of this mechanism
in the context of aSyn pathobiology.
Posttranslation modifications modulate the degradation of
aggregate-prone proteins by the UPS and/or autophagy. Ubiqui-
tination generally determines whether a protein is degraded via the
UPS or autophagy [71]. Interestingly, phosphorylation of mutant
huntingtin (Htt), the protein associated with Huntington’s disease,
was found to precede and regulate additional posttranslational
modifications, including ubiquitination, SUMOylation, and acet-
ylation, enhancing its normal clearance by the proteasome and
lysosome [72]. In particular, acetylation of mutant huntingtin
promotes its targeting to autophagosomes, facilitating its specific
degradation by the autophagy/lysosomal pathway [73].
The impact of aSyn S129 phosphorylation on its clearance only
started to be investigated recently. In neuronal cell lines, it was
observed that proteasome inhibition results in increased levels of
pS129 aSyn as an outcome of either increased activity of the
kinase(s) involved or decreased phosphatase activity, together with
decreased degradation of pS129 aSyn by the proteasome in an
ubiquitin-independent manner [74,75].
Recently, overexpression of GRK6, one of the kinases capable
of phosphorylating aSyn at S129 [76], was found to moderately
increase aSyn toxicity in a rat model of familial PD [77]. In
contrast, another recent study showed that the overexpression of
another kinase, the Polo-like kinase 2 (PLK2) [78], is protective by
mediating selective autophagy clearance of pS129 aSyn [79]. This
apparent discrepancy could be the reflex of the different
efficiencies of these kinases to phosphorylate aSyn at S129. In
our yeast model, we completely abolished aSyn phosphorylation
by replacing S129 with neutral and phosphorylation-resistant
amino acids (alanine or glycine). In fact, our results are consistent
with those recently reported [79], since we observed that blocking
aSyn phosphorylation compromises its degradation. The clearance
of the inclusions formed by S129A aSyn was slower than that of
inclusions formed by WT aSyn. Moreover, our findings suggest
that autophagy is the main mechanism involved in aSyn clearance
in our yeast PD model. Whereas the accumulation of WT aSyn led
to a marked induction of autophagy, cells expressing the S129A
mutant failed to activate this pathway. Thus, we postulate that
S129 phosphorylation might constitute a switch to sense and
induce the autophagocytic pathway, and that blocking phosphor-
ylation impairs autophagic induction, albeit without altering
autophagic flux. Genetic impairment of yeast autophagy by
deletion of ATG1 and ATG7 did not significantly affect the levels of
WT or S129A aSyn after 6 hours of induction suggesting that, at
this time point, clearance by autophagy is not superimposed to
protein synthesis or that cells could compensate autophagy
impairment through other clearance pathways, as suggested by
studies performed in other cellular models [38,39,80]. However,
ATG7 deletion increases the defect on the clearance of S129A
aSyn-GFP but it also has a significant effect on WT aSyn-GFP
clearance. This effect could be due to the accumulation of different
aSyn species formed by S129A or WT aSyn, as we clearly
demonstrated in this study. While soluble and smaller oligomeric
species of aSyn could be more easily cleared by the proteasome
and CMA, as reported in other models [32,33,81,82], the larger
oligomeric species formed by S129A aSyn-GFP could specifically
require autophagy function for clearance. Our observation that
aSyn accumulation leads to impairment of proteasome function, as
Figure 11. Impairment of autophagy decreases S129A aSyn-GFP clearance and increases toxicity. (A) WT and S129A aSyn-GFP
expression levels assessed by western blot analysis of total protein extracts at the indicated time points of aSyn-GFP clearance (left panel).
Densitometric analysis of the immunodetection of aSyn relative to the intensity obtained for PGK used as loading control, presented in arbitrary units
(a.u.) (right panel). (B) Intracellular localization of WT or S129A aSyn-GFP (left panel) and percentage of cells containing aSyn-GFP inclusions assessed
by fluorescence microscopy at the indicated time points of aSyn clearance (right panel). (C) Side scatter (SSC) and aSyn-GFP fluorescence assessed by
flow cytometry, at 6 hours of aSyn clearance (upper panel). The frequency of parent of the sub-population of yeast cells presenting higher levels of
GFP fluorescence is represented in the lower panel. (D) SSC versus Propidium Iodide (PI) fluorescence and Frequency of PI positive cells assessed by
flow cytometry after 6 hours of aSyn clearance. (***p,0.001; **p,0.01, *p,0.05; one way ANOVA with Bonferroni’s multiple comparison test). A
representative result is shown from at least four independent experiments. Values represent the mean 6 SD.
doi:10.1371/journal.pgen.1004302.g011
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previously observed [83], is also consistent with this hypothesis,
and this impairment is at least partially reverted when aSyn
expression is blocked.
Pharmacological inhibition of the proteasome did not alter the
clearance of inclusions in our yeast model, in agreement with
previous studies [25]. However, it is now evident that autophagy
and proteasome function are deeply interconnected and that
inhibition of either one of these pathways results in the com-
pensatory upregulation of the other [38,80]. Thus, we postulate
that upon aSyn-mediated proteasome impairment, autophagy is
upregulated as a compensatory mechanism to deal with the excess
of aSyn.
In this study, we provide evidence supporting a novel link
between aSyn phosphorylation, aggregation and cellular toxicity
using a simple but powerful model organism. The finding that the
phosphorylation state of aSyn on S129 can have an impact in the
ability for cells to clear aSyn inclusions opens novel avenues for
intervention in synucleinopathies through the modulation of aSyn
phosphorylation.
Materials and Methods
Plasmids and yeast strains
The yeast strains used in this work are described in Table 1.
VSY71 to VSY74 contain double genome insertions of GAL1pr-
SNCA(WT, S129A or S129E)-GFP or of the empty vectors and
were previously described [42].
Plasmids p304 GAL1pr-SNCA(S129G)-GFP and p306 GAL1pr-
SNCA(S129G)-GFP were generated by site directed mutagenesis of
the corresponding plasmids carrying the WT SNCA gene. These
plasmids were linearized with EcoRV for integration into W303-
1A and W303-1B strains, respectively. The correct insertion of the
integrative vectors was verified by PCR and the haploid strains
were used to generate a diploid strain by mating. Diploids were
selected in minimal medium by URA and TRP prototrophy.
Haploid strains carrying the double insertion of SNCA S129G were
obtained by sporulation and tetrad dissection followed by analysis
of auxotrophy and mating type verification. The phenotypic
characterization was performed in several haploid strains obtained
from dissected spores from independent tetrads and independent
mating.
NLS-TagRFP657 was cloned into pESC (GAL1pr, LEU2;
Stratagene) [84] and used in fluorescence microscopy to visualize
cells nuclei.
VSY71 to VSY73 strains with the deleted PDR5, ATG1 or ATG7
genes, were constructed by gene replacement with a cassette
generated by PCR comprising the kanamycin gene (KanMX4)
resistance gene flanked by 250 bp gene specific homologous 59-
and 39- targeting regions. PDR5, ATG1 or ATG7 deletion was
confirmed by PCR (Table 1).
VSY71 to VSY73 2xmCherry-ATG8 strains contain single
genome insertion of the pRS305 2xmCherry-ATG8 plasmid and
were constructed by integration of the EcoRV-linearized pRS305-
derived plasmid (Table 1). The 2xmCherry-ATG8 fragment was
excised from the pRS316 2xmCherry-ATG8 plasmid [85] (a kind
gift from Dr. Kuninori Suzuki, Tokyo Institute of Technology), by
SacI/KpnI digestion and inserted in the empty pRS305 plasmid,
to generate the pRS305 2xmCherry-ATG8 plasmid.
VSY71 to VSY73 Pup1p-RFP strains contain an integrated
RFP (tdimer2;12) at the 39 end of the Pup1 endogenous loci and
were constructed by integration of the EcoNI-linearized pRS305-
derived plasmid. The Pup1p-RFP tag was excised from the
original plasmid [86] (kindly provided by Dr. Isabelle Sagot,
Institut de Biochimie et Ge´ne´tique Cellulaires), by SacI/HindIII
digestion and inserted in the empty pRS305 plasmid, to generate
the pRS305 Pup1p-RFP plasmid.
The genes encoding modifiers of aSyn toxicity YPT1, YKT6,
BRE5, UBP3, GYP8, and PMR1 were kindly provided by Dr.
Aaron Gitler, Stanford University, cloned in Gateway entry clones
[28] and used to generate expression clones on the pRS based
gateway vectors pAG305GAL (YPT1, YKT6, UBP3, GYP8, and
PMR1) or pAG303GAL (BRE5) [87]. These plasmids were
integrated in the VSY71, VSY72 and VSY73 genome to generate
new strains (Table 1).
The vesicles markers Ypt1, Ypt31, Sec4, Ypt6, Vps21, Ypt52
and Ypt7 used on fluorescence microscopy experiments were
constructed by Gitler and co-workers [27] and were obtained from
Addgene (pAG416GPD-Cerulean-YPT1, 18848; pAG416GPD-
Cerulean-YPT31, 18849; pAG416GPD-Cerulean-SEC4, 18844;
pAG416GPD-Cerulean-YPT6, 18845; pAG416GPD-Cerulean-
VPS21, 18842; pAG416GPD-Cerulean-YPT52, 18843;
pAG416GPD-Cerulean-YPT7, 18847). These clones were used
to generate entry clones by recombination cloning into a Gateway
pDONR221 vector (Invitrogen). These clones were then used to
generate new integrative vectors in the pAG305 GPD-Cerulean-
ccdB vector which were verified by DNA sequencing. These
plasmids were integrated in the VSY71, VSY72 and VSY73
genome to generate new strains (Table 1).
The P-bodies marker encoding the gene DCP1 cloned in
pBG1805-DCP1 was obtained from the Open Biosystems Yeast
ORF Collection and used to generate an entry clone into Gateway
pDONR221 vector (Invitrogen). This clone was then used to
generate a new integrative vector in the pAG305GPD-ccdB-DsRed
vector which was verified by DNA sequencing. This plasmid was
integrated in the VSY71, VSY72 and VSY73 genome to generate
new strains (Table 1). Construction of pESC JEN1-mCherry plasmid
was performed by ligating BamHI-JEN1-XhoI fragment generated
by PCR amplification of chromosome DNA with oligonucleotides
containing flanking corresponding restriction enzyme sites into
BamHI-pESCmCherry-XhoI plasmid. mCherry was subcloned into
pESC (LEU) plasmid following XhoI/NdeI restriction sites.
Yeast transformations were carried out using a standard lithium
acetate procedure and all the genome insertions were confirmed
by two independent PCRs following standard procedures [88].
Yeast culture conditions and CFUs determination
For aSyn expression induction experiments, yeast cells were pre-
grown in YEP-Raffinose (peptone 2%, yeast extract 1%, raffinose
1%) liquid media at 30uC, with orbital agitation (200 rpm) for
24 hours (doubling time: ,3 hours). After 24 hours, optical
density at 600 nm (OD600 nm) was measured and yeast cells were
diluted to a standardized OD600 nm= 3610
23 (,2.56105 cells/
mL) in YEP-Raffinose liquid media and grown at 30uC, with
orbital agitation (200 rpm). After 24 hours, OD600 nm was
measured. The volume of yeast culture needed to inoculate a
new culture with an initial standardized OD600 nm= 0.2 (,76106
cells/mL) was centrifuged (3000 rpm, at 30uC for 4 min). Cells
were then resuspended in YEP-Galactose (peptone 2%, yeast
extract 1%, galactose 1%) liquid media and incubated at 30uC,
with orbital agitation (200 rpm), for 6 hours. The cell viability was
assessed by counting CFUs after incubation of culture aliquots for
2 days at 30uC on YEP-glucose agar plates.
For spot assays cell suspensions were adjusted to OD600nm=
0.0560.005 and used to prepare 1/3 serial dilutions that were
applied as spots (4 ml) onto the surface of the YPD rich medium
used as control or YEP-Galactose medium and incubated at 30uC
for 2–3 days.
Phosphorylation Modulates aSyn Clearance in Yeast
PLOS Genetics | www.plosgenetics.org 18 May 2014 | Volume 10 | Issue 5 | e1004302
For aSyn clearance experiments, OD600 nm of the 6 hours
induced cultures was measured and the volume of yeast culture
needed to inoculate a new culture with an initial standardized
OD600 nm= 0.2 (,76106 cells/ml) was centrifuged (3000 rpm, at
30uC for 4 min). Cells were washed in PBS and resuspended in
YEP-Glucose (peptone 2%, yeast extract 1%, glucose 2%) liquid
media and incubated at 30uC, with orbital agitation (200 rpm), for
6 hours.
For fluorescence microscopy or flow cytometry analysis, adenine
was added to the growth media at a final concentration of
0.16 mg/mL to avoid background interactions by the red pigment
production due to ade2 auxotrophic marker of the used yeast
strain. Adenine supplementation did not alter growth phenotypes
of the tested yeast strains.
Flow cytometry
Yeast cell membrane integrity was evaluated with PI staining
using a BD LSR Fortessa. Yeast cells were incubated with PI
5 mg/mL for 15 min. As a positive control, cells boiled for 10 min
were used (data not shown).
Autophagy induction was determined measuring fluorescence
intensity of mCherry-Atg8 under the regulation of the natural
promoter [85] in cells co-expressing WT or S129A aSyn-GFP,
using a BD FACSAria III equipped with a 561 nm laser for
excitation and a 600 LP mirror in conjunction with a 610/20 BP
filter for detection (BD Biosciences, San Jose, CA). Fluorescence
intensity of WT or S129A aSyn-GFP was measured in simulta-
neous using a 488 nm laser for excitation and a 502 LP mirror in
conjunction with a 530/30 BP filter for detection (BD Biosciences,
San Jose, CA).
A minimum of 10.000 events were collected for each
experiment. Data analysis was performed using FlowJo software
(Tree Star Inc., Ahsland, OR, USA). Results were expressed as
median fluorescence intensity (MFI) of a molecule.
Protein extraction and western blot analysis
For total protein extraction, yeast cells were lysed in Tris-HCl
buffer pH 7.6 supplemented with protease and phosphatases
inhibitor cocktail (Roche, Mannheim, Germany), with glass beads
(3 cycles of 30 seconds in the beadbeater and 1 min on ice). Cell
debris was removed with a smooth centrifugation (700 g, 3 min,
4uC) and the supernatant was collected. The supernatant was
sonicated (10 seconds at 10 mA, Soniprep 150 from Sanyo).
Protein concentration was determined using the BCA protein
assay kit (Thermo Fisher Scientific Inc, Illinois, USA). The same
amount of total protein was loaded in the SDS-PAGE for the
detection of mCherry-Atg8 levels. As WT and mutant aSyn
expression cells exhibit slightly distinct growth rates, equal volumes
of total protein, corresponding to the same number of cells
(normalized based on OD600 nm) were applied to the SDS-PAGE
for aSyn quantification in induction, clearance and proteasome
pharmacological inhibition experiments, in order to avoid bias in
the protein measurement levels due to a cell dilution effect.
Protein sample buffer (200 mM Tris-HCl pH 6.8, 6% 2-
mercaptoethanol, 8% SDS, 40% glycerol, 0.4% bromophenol
blue) was added to each protein sample and heated for 10 min at
100uC before acrylamide gel loading. Protein samples were run in
SDS-PAGE and were transferred to a nitrocellulose membrane
using a Trans-Blot Turbo transfer system (Bio-Rad), as specified
by the manufacturer. Immunoblotting was performed following
standard procedures with the listed antibodies: aSyn (BD
Transduction Laboratories, San Jose, CA, USA), pS129-aSyn
(Wako Chemicals USA, Inc., Richmond VA, USA) and DsRed
(Clontech Laboratories, Inc. USA). GAPDH (Ambion, Cambrid-
geshire, UK) or PGK (Life Technologies, Grand Island, NY, USA)
were used as loading control.
The band intensity of the different immunoblots signals was
estimated using ImageJ software (NIH, Bethesda, MD) and
normalized against the corresponding GAPDH or PGK signal.
In particular, aSyn levels were determined by calculating the ratio
between aSyn/GAPDH and normalized to the control (mean 6
SD); pS129-aSyn levels were determined by doing the ratio
between both values: (pS129/GAPDH)/(aSyn/GAPDH) and
normalized to the control (mean 6 SD). Atg8 induction was
quantified by the determination of the fold increase of total
mCherry signal (mCherry-Atg8 and free mCherry signal, detected
with anti-DsRed) normalized to GAPDH [89]; autophagic flux
was quantified by measuring the vacuolar degradation of the Atg8
domain reporter (ratio of free mCherry to total mCherry signal)
[50].
Triton soluble and insoluble fractions
Total protein was extracted and quantified with the BCA
protein assay kit (Thermo Fisher Scientific Inc, Illinois, USA).
200 mg of total protein was incubated with 1% Triton X-100 on
ice, for 30 min. Protein fractions were separated by centrifugation
at 15000 g for 60 min at 4uC. The top soluble protein fraction
(Triton-soluble, TS) was collected and the insoluble protein
fraction (Triton-insoluble, TI) pellet was resuspended in 40 ml of
2% SDS Tris-HCl buffer pH 7.4 by pipetting and subsequent
sonication (10 seconds). Equal volumes of TS and TI were loaded
and resolved by SDS-PAGE.
Sucrose gradient and size exclusion chromatography
Total protein from cells expressing WT or S129A aSyn was
obtained and applied on a 5 to 30% sucrose gradient as described
before [90,91]. Fractions were collected, precipitated for 4 hours
at 4uC in trichloroacetic acid, washed in acetone three times and
suspended in protein sample buffer (0.5 M Tris-HCl, pH 6.8,
Glycerol, 10% SDS, 0.1% Bromophenol Blue). Proteins were
resolved by SDS-PAGE and estimation of the molecular sizes for
each fraction was previously described [92].
Size exclusion-fast protein liquid chromatography (SEC-FPLC)
was performed with total protein lysates from cells expressing WT
or S129A aSyn-GFP extracted as described for sucrose gradient
[90,91], centrifuged at 16000 g for 4 min and filter with 0.45 mM
PVDF (Whatman) to remove any insoluble particles. Samples
(3 mg of protein in final volume of 500 mL) were analyzed on a
Superose 6 10/300 GL column (GE Healthcare, Uppsala,
Sweden) using a FPLC system with UV-M II detector (GE
Healthcare, Uppsala, Sweden). The samples were eluted with
50 mM ammonium acetate, pH 7.4 at a flow rate of 500 mL/min
and the UV absorbance was monitored at 280 nm. To estimate
the molecular weight of the protein samples, High Molecular
Weight and Low Molecular Weight gel filtration calibration kits
were used (GE Healthcare, Uppsala, Sweden). Fractions of 500 mL
were collected, precipitated overnight at 4uC in trichloroacetic
acid, washed in acetone three times and resuspended in protein
sample buffer (0.5 M Tris-HCl, pH 6.8, Glycerol, 10% SDS,
0.1% Bromophenol Blue), and were resolved by SDS-PAGE.
Fluorescence 3D time-lapse (4D imaging)
For time-lapse imaging, VSY yeast cells transformed with
pESC-Leu GAL1pr NLS-TagRFP657 were pre-grown overnight
in Synthetic complete (SC) medium without leucine (SC-Leu)
raffinose liquid media at 30uC, with orbital agitation (200 rpm).
OD600 nm was measured and yeast cells were diluted to a
standardized OD600 nm= 0.8 (,2.46107 cells/ml) in SC-Leu
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raffinose liquid media and grown at 30uC, with orbital agitation
(200 rpm). After 6 hours, cells were seeded on concanavalin A-
coated 4-well microscope plates (Greiner Bio-One GmbH) for
about 10 min. Then all media was replaced by SC-Leu Galactose
for aSyn and NLS-TagRFP657 expression induction. Confocal 3D
movies were acquired using a dual point-scanning Nikon A1R-si
microscope equipped with a PInano Piezo stage (MCL), using a
60x PlanApo IR water objective NA 1.27 and PlanApo VC oil
objective 960x) NA 1.40, 0.35 micron slices, and 0.5% laser power
(from 5 mW 488 laser and 40 mW 561 laser). Prior to imaging the
point-spread function was visualized with 100 nm fluorescence
beads in order to adjust the correction ring of the objective to the
coverslip thickness. Movies were acquired in resonant-scanning
mode. Z-stacks were acquired every 10 min for 18 hours with
some exceptions. Each z-series was acquired with 0.35 micron step
size and 30 total steps, images - in galvano scanning mode (0.4
micron slices). Image processing was performed using NIS-
Elements software.
Fluorescence microscopy and FRAP experiments
The percentage of cells with aSyn inclusions, number of aSyn
inclusions per cell and size of aSyn inclusions were determined by
fluorescence microscopy using a Zeiss Axiovert 200 M (Carl Zeiss)
widefield fluorescence microscope equipped with a cooled CCD
camera (Roper Scientific Coolsnap HQ) to acquire images
containing at least 700 cells per strain, which were then manually
counted using ImageJ. Colocalization studies were performed with
a Zeiss Axiovert 200 M (Carl Zeiss) widefield fluorescence
microscope equipped with a cooled CCD camera (Roper Scientific
Coolsnap HQ) or a Zeiss LSM 710 inverted laser scanning
confocal microscope (Carl Zeiss) using a Plan-Apochromat 63x/
1.4 oil immersion objective. EGFP fluorescence was detected using
the 488 nm laser line of an Ar laser (25 mW nominal output) and
a custom wavelength detection window set to 493–556 nm.
mCherry and RFP fluorescence were detected using a 561 nm
DPSS laser (15 mW) and a custom detection window set to 569–
797 nm.
Yeast cells were grown as described above. At the indicated time
points cells were collected by centrifugation and resuspended in
PBS and 0.5% low melting agarose on a microscope slide.
FRAP experiments were performed using a Zeiss LSM 710
inverted laser scanning confocal microscope equipped with a large
incubator (Pecon, Erbach, Germany) maintained at 30uC. Images
were acquired using a PlanApochromat 63x/1.4 objective. A series
of 80 z-stacks consisting of 5 different focal planes spaced 0.7 mm
apart (frame size 5126512, pixel width 91 nm and pixel time
4.44 ms) were acquired at intervals of 2 seconds with pinhole set to
1 Airy unit. In each FRAP experiment a single inclusion, focused
at the central focal plane of the z-stack, was bleached using the
488 nm laser line at 100% laser transmission on a circular region
of interest (ROI) with a diameter of 8 pixels (0.35 mm radius) for
32 ms. For imaging, the transmission of the 488 nm laser was set
to 0.3% of the bleach intensity.
Image processing and fluorescence intensity measurements were
performed in ImageJ using an in-house developed macro to
extract the average fluorescence in the bleached area I(t) at the
central plane of the z-stack at each time point t and the average
cellular fluorescence intensity T(t) which was used to normalize
FRAP recovery curves as described previously [93].
Irel(t)~
I(t)
I0
T0
T(t)
where T0 is the fluorescence in the total cell area before bleaching
and I0 is the fluorescence in the bleached region before bleaching.
Post-bleach values were additionally set to zero to facilitate
comparison of the curves.
FRAP recovery curves were fit to a single-exponential curve
assuming a binding-dominant (diffusion-uncoupled) regime where
protein diffusion occurs much faster than binding kinetics [94].
Irel(t)~(1{IF )(1{e
{koff t)
where IF is the immobile fraction and koff is the off rate of binding
which can be used to determine the mean residence time T=1/
koff. Curve fitting was performed on OriginPro 8 (OriginLab
Corporation).
Statistical analysis
Statistical analysis were performed using unpaired tow-tailed t-
test; one way ANOVA with Bonferroni’s or Tuckey multiple
comparison test; two-tailed unpaired t-test with Welch’s correc-
tion; two-tailed Mann-Whitney test, where appropriate. P-value #
0.05 was considered statistically significant. Statistics were
performed using Prism 5 and SigmaStat (GraphPad Software
Inc.).
Supporting Information
Figure S1 S129A aSyn is more toxic than WT aSyn. (A) Cell
viability determined by CFUs during the initial time points of the
growth curve (shown in Figure 1A) of yeast cells expressing either
WT (%), S129A (m) or S129E (#) aSyn-GFP, compared to cells
that are not expressing the human protein (e). Cells used as
inoculum were exponential-phase cells cultivated in raffinose
medium that at time zero were transferred to galactose medium to
induce aSyn expression. Values are representative from three
independent experiments. (B) Spotting assay of the indicated yeast
cells. The cell suspensions with adjusted OD600nm were serially
diluted and spotted onto the surface of solid medium containing
either glucose (control) or galactose (induced aSyn expression) as
carbon source. A representative result is shown from at least three
independent experiments.
(TIFF)
Figure S2 S129G aSyn behaves similarly to S129A asyn. (A)
Spotting assay of the indicated yeast cells. The cell suspensions
with adjusted OD600nm were serially diluted and spotted onto the
surface of solid medium containing either glucose (control) or
galactose (induced aSyn expression) as carbon source. Results
shown are from one representative experiment from at least three
independent experiments. (B) WT, S129A or S129G aSyn-GFP
expression and pS129 levels in yeast cells assessed by western blot
analysis of total protein extracts 6 hours after aSyn-GFP
expression induction. PGK was used as loading control. (C)
Intracellular localization of the WT, S129A or S129G aSyn-GFP
(left panel) and percentage of yeast cells containing aSyn inclusions
(right panel), after 6 hours of aSyn expression induction, assessed
by fluorescence microscopy (**p,0.01; one way ANOVA and
post-hoc Tukey test). Results shown are from one representative
experiment from at least three independent experiments. Values
represent the mean 6 SD.
(TIFF)
Figure S3 Elution profiles of SEC from total protein extracts of
cells expressing WT or S129A aSyn-GFP. Equal amounts of total
protein (,3 mg) from cells not expressing aSyn (empty) or
expressing either WT or S129A aSyn-GFP were separated in a
Superose 6 10/300 GL column. A calibration curve for SEC was
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performed using protein molecular weight markers (ferritin,
440 kDa; aldolase, 158 kDa; conalbumin, 75 kDa; ovalbumin,
44 kDa, and aprotinin, 6.5 kDa). The elution time of the protein
markers is indicated in the figure. Results shown are from one
representative experiment from at least three independent
experiments. Values represent the mean 6 SD.
(TIFF)
Figure S4 S129 phosphorylation levels of WT aSyn are not
altered during aSyn clearance. WT aSyn and pS129 levels at the
indicated time points of aSyn clearance (left panel). Densitometric
analysis of the pS129-aSyn levels by determining the ratio of the
pS129 and the total levels of aSyn (pS129/PGK)/(aSyn/PGK)
and normalized to the control. Results shown are from one
representative experiment from at least four independent exper-
iments. Values represent the mean 6 SD.
(TIFF)
Figure S5 aSyn protein dynamics in inclusions. FRAP recovery
curves of the aSyn WT and S129A inclusions shown in Figure 5
are well fit with a single exponential curve. FRAP experiments
were performed at (A) 0 hours and (B) at 6 hours of clearance. The
aSyn immobile fraction (IF) and the aSyn mean residence time (T)
values were calculated from the single exponential fit. Values
represent the mean 6 SD.
(TIFF)
Figure S6 aSyn inclusions from PI-positive cells expressing
S129A aSyn do not recover after photobleaching. (A) Time lapse
recording of the fluorescence recovery after photobleaching of
aSyn inclusions in three representative PI positively marked cells
expressing aSyn S129A after 6 hours of expression induction and
the corresponding (B) FRAP recovery curve of cells shown in (A).
(TIFF)
Figure S7 Inclusions formed by WT or S129A aSyn do not
colocalize with IPOD, JUNQ or P-bodies markers. Confocal
microscopy images of cells co-expressing either WT or S129A
aSyn-GFP and mCherry-Atg8, Pup8-RFP or Dcp1-DsRed after
6 hours of aSyn expression induction. Results shown are from one
representative experiment from at least three independent
experiments.
(TIFF)
Figure S8 Inclusions formed by WT or S129A aSyn colocalize
with vesicular trafficking markers. Fluorescence microscopy
images of cells co-expressing either WT or S129A aSyn-GFP,
and the indicated vesicular trafficking markers with N-terminal
fusions with cerulean, after 6 hours of aSyn expression induction.
Results shown are from one representative experiment from at
least three independent experiments.
(TIFF)
Figure S9 The proteasome is not involved in the clearance of
S129A aSyn-GFP. (A) WT, S129A aSyn-GFP expression levels in
WT or Dpdr5 yeast cells assessed by western blot analysis of total
protein extracts 6 hours after aSyn-GFP expression induction. (B)
Percentage of Dpdr5 cells with WT or S129A aSyn-GFP inclusions,
before and after 3 hours of clearance in the presence of MG132 in
DMSO or only DMSO. (C) WT and S129A aSyn-GFP expression
levels at the same time points and subject to the same treatments as
in (B), determined by western blot analysis of protein total extracts
from Dpdr5 yeast cells. The total levels of ubiquitinated proteins
were also evaluated by immunoblotting to confirm the effective-
ness of the MG132 as proteasome activity inhibitor. Results shown
are from one representative experiment from at least three
independent experiments. Values represent the mean 6 SD.
(TIFF)
Figure S10 Impairment of autophagy do not affect aSyn S129
phosphorylation. WT aSyn-GFP pS129 levels assessed by western
blot analysis of total protein extracts at the indicated time points of
aSyn-GFP clearance (left panel). Densitometric analysis of the
pS129-aSyn levels by determining the ratio between pS129 and
the total levels of aSyn (pS129/PGK)/(aSyn/PGK) and normal-
ized to the control (right panel) (*p,0.05; one way ANOVA with
Bonferroni’s multiple comparison test). A representative result is
shown from at least three independent experiments. Values
represent the mean 6 SD.
(TIFF)
Movie S1 High-resolution 4D imaging of yeast cells expressing
WT aSyn-GFP. Nuclei are marked with NLS-TagRFP657.
Images were acquired every 10 min for 18 hours after induction
of aSyn expression.
(AVI)
Movie S2 High-resolution 4D imaging of yeast cells expressing
S129A aSyn-GFP. Nuclei are marked with NLS-TagRFP657.
Images were acquired every 10 min for 18 hours after induction of
aSyn expression.
(AVI)
Movie S3 High-resolution 4D imaging of yeast cells expressing
WT aSyn-GFP and Jen1-mCherry. Images were acquired every
10 min after induction of aSyn expression.
(AVI)
Movie S4 High-resolution 4D imaging of yeast cells expressing
WT aSyn-GFP) and Jen1-mCherry). Images were acquired every
10 min after induction of aSyn expression.
(AVI)
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